Kelly Byrnes-Blake has over 18 years of experience as a pharmacokineticist supporting drug research and development. Kelly earned a PhD in pharmacology, with specific training in pharmacokinetics, in 2001. During her years in the pharmaceutical and biotech industry, she has supported the development of both small molecule and protein-based therapeutics. Her experience includes taking several protein-based therapeutic projects from early research through IND-enabling studies and into Phase 1 and 2 clinical trials. Kelly is a co-author on several peer-reviewed scientific publications and abstracts.
In 2011, Kelly founded Northwest PK Solutions, LLC. Her services include designing, monitoring, and reporting of PK, PK/PD, TK, and biodistribution studies. In addition, she provides scientific expertise on issues regarding interspecies scaling and dose/regimen selection for preclinical toxicology and first-in-human studies. She helps investigate the relationship between PK and efficacy/safety biomarkers. Kelly also aids with scientific writing, contributing PK sections for patents, Investigator's Brochures, INDs, and other regulatory submissions.
To provide clients with pharmacokinetic expertise and services to facilitate the development of drug and protein therapeutics. If your company needs a PK consultant who will address your needs in a timely manner, pay attention to detail, and maintain an open line of communication to facilitate the accomplishment of your company goals, contact Northwest PK Solutions, we can help.
Copyright © 2019 Northwest PK Solutions - All Rights Reserved.